Clinical efficacy of haridra in prameha purvaroop w.s.r. to prediabetes

Abstract

Diabetes is a non-communicable disease which is attaining increasing importance among the adult population in both developed and developing countries. Pre-diabetes is a precursor condition for type 2 Diabetes mellitus. Although in many cases it is reversible, Pre-diabetes frequently remains undiagnosed and therefore risk of developing type 2 Diabetes Mellitus is increased. Lifestyle modification is more effective mode of preventing diabetes and reduction of 40%-70% with pre-diabetes. While there is increasing evidence to prove the efficacy of pharmacotherapy in prevention of diabetes in adults with pre-diabetes, pharmaceutical treatment options other than metformin are associated with adverse effects that limit their use for pre-diabetes. It is considered to be an at risk state, with high chances of developing diabetes. While, pre-diabetes is commonly an asymptomatic condition, there is always presence of pre-diabetes before the onset of diabetes. This aim of this study is to describe the challenges associated with diagnosis of pre-diabetes, the possible adverse medical outcomes associated with pre-diabetes and the treatment options and rationale for their use in context of pre-diabetes. This research topic is selected for prevention of type 2 Diabetes Mellitus by identification of high risk subjects and early dietary intervention in the form of Haridra. Therefore, an attempt has been made to study the clinical efficacy of Haridra In Prameha Purvaroop W.S.R. To Prediabetes.